Advertisement

Topics

Latest "Cazenove Group Limited" News Stories

17:17 EDT 24th April 2018 | BioPortfolio

Here are the most relevant search results for "Cazenove Group Limited" found in our extensive news archives from over 250 global news sources.

More Information about Cazenove Group Limited on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Cazenove Group Limited for you to read. Along with our medical data and news we also list Cazenove Group Limited Clinical Trials, which are updated daily. BioPortfolio also has a large database of Cazenove Group Limited Companies for you to search.

Showing "Cazenove Group Limited" News Articles 1–25 of 11,000+

Relevant

JPMorgan Cazenove provides wrong medicine for Shire, downgrading its rating to ‘neutral’

JPMorgan's analysts said: “Valuation remains undemanding, but with few 2018 or 2019 catalysts beyond a potential NeuroScience spin, which we do not see creating fundamental value, we struggle to see outperformance this year”


Genetic Technologies Limited: Update on Strategic Alliance

MELBOURNE, Australia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), wishes to advise that the Company is presently in discussions with the ASX regarding the possible application of ASX Listing Rule 11.1; its structure / operations in compliance with ASX Listing Rule 12.5 and whether a strategic alliance with Blockchain Globa...

Genetic Technologies Limited: Project Shivom Strategic Alliance

MELBOURNE, Australia, March 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG)  (NASDAQ:GENE) (“Company”, “GTG”) a diversified molecular diagnostics company; provider of BREVAGenplus®, a first-in-class, clinically validated risk assessment test for sporadic (non-hereditary) breast cancer, embracing blockchain technologies across genomic testing platforms, is pleased...


Telix Pharmaceuticals Limited Lists on the Australian Securities Exchange

MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has today listed on the Australian Securities Exchange (ASX) after raisin...

Quotient Limited Announces Appointment of Franz Walt as Non-Executive Director

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the appointment of Franz Walt to its board of directors effective February 19, 2018 Mr. Walt joins Quotient’s board of directors with over 29 years of experience in leadership roles at two of the largest, most influential healthcare compan...

Quotient Limited to Participate in the Jefferies 2017 London Healthcare Conference

JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Jefferies 2017 London Healthcare Conference on Thursday, November 16, 2017 at 9:20 a.m. GMT (4:20 a.m. Eastern Time) at the Waldorf Hilton in London, U.K. ...

Immutep Limited Announces Milestone Payment From Chinese Partner EOC Pharma

SYDNEY, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) announced today that it has received a milestone payment from the Company’s Chinese partner for eftilagimod alpha (IMP321), EOC Pharma, an oncology focused affiliate of Eddingpharm. The milestone payment of US$1 million relates to the clinical development of eftilagimod alpha in China and follows ...

Quotient Limited to Participate in the 36th Annual J.P. Morgan Healthcare Conference

JERSEY, Channel Islands, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the 36th Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2018 at 10:30 a.m. PST (1:30 p.m. EST) at the Westin St. Francis Hotel, in San Francisco...

Quotient Limited to Participate in the LEERINK Partners 7th Annual Global Healthcare Conference

JERSEY, Channel Islands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the LEERINK Partners 7th Annual Global Healthcare Conference on Wednesday, February 14th, 2018 at 1:30 p.m. EST at the Lotte New York Palace Hotel, in New York, NY...

Quotient Limited Announces the Sale and Leaseback of its Edinburgh, Scotland Manufacturing and R&D Facility

JERSEY, Channel Islands, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced it has entered into definitive agreements for the sale and leaseback of its recently completed Biocampus facility located near Edinburgh, Scotland. Biocampus is a state-of-the-art facility designed to house Quotient’s rapidly growing liquid re...

Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference

JERSEY, Channel Islands, March 01, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, will present at the Cowen 38th Annual Global Health Care Conference on Tuesday, March 13th, 2018 at 8:00 a.m. EDT at The Boston Marriott Copley Place, in Boston, MA. The Compan...

20152023 World MultiWalled Carbon Nanotubes Market Research Report by Product Type, EndUser / Application and Regions / Countries [Report Updated: 01072017] Prices from USD $2800

SummaryThis report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.Market Segment as follows:By Region / Countries North America U.S., Canada, Mexico Europe Germany, U.K., France, Italy, Russia, Spain etc South Americ...

Quotient Limited to Report Fiscal Third Quarter 2018 Financial Results and Host Conference Call

JERSEY, Channel Islands, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, 2017, will be released after market close on Monday, February 5, 2018. Quotient will host a conference call on Tuesday, February 6, 2018 at 8:30 a.m. Eastern Time to discuss...

Quotient Limited Updates on Status of MosaiQ Performance and Provides Third Quarter Fiscal 2018 Financial Results

Manufacturing process change implemented with improved assay performance Verification and Validation (V&V) studies for blood grouping to resumeMosaiQ SDS Microarray preparing to enter into formal V&V studiesEuropean Field Trials to commence following completion of V&V studiesConventional reagent business continues strong revenue and profitability growth JERSEY, Channel Islands...

Global and China MultiWalled Carbon Nanotubes Market Research by Company, Type Application 20132025 [Report Updated: 05032018] Prices from USD $2000

SummaryMarket Segment as follows:By Type Palm Oil Soybean Oil Sunflower Oil Rapeseed Oil Olive Oil OthersBy Application Electronic Products Semiconductor Medical Advanced Materials Aviation OthersBy Company ARKEMA S.A. HANWHA CHEMICAL CO. LTD. KUMHO PETROCHEMICAL SHOWA DENKO K.K Toray Industries CNANO TECHNOLOGY LIMITED NANOCYL S.A. HYPER...

Probably Relevant

Innovation Pharmaceuticals Views Brilacidin-OM as Clearly Differentiated Compared to Limited Competition for Preventing Severe Oral Mucositis

BEVERLY, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide shareholders with a status report on the development of Brilacidin-OM, Innovation Pharma’s novel defensin mimetic drug candidate for the prevention and treatment of Severe Oral Mucositis (SOM) in Head and Neck Canc...

Quotient Limited Reports Further Positive Data on its Initial Disease Screening Microarray and Provides Update on Blood Grouping

Performance evaluation studies for the initial disease screening microarray demonstrate 100% sensitivity and >99% specificity for the CMV and Syphilis assaysV&V for blood grouping is ongoing – pending a modification to the manufacturing process designed to further improve microarray performanceAssays for the MosaiQ blood grouping Microarray continue to perform robustly JERSEY, Channel...

Huobi Group and SBI Group reached a strategic partnership agreement to jointly develop Global ...

Huobi Group was founded in 2013. After four years of steady operation, the Group has become a leading global digital asset financial service provider in Read more...

TMX Group Limited Declares Dividend of $0.50 per Common Share

For the results of the quarter ended December 31, 2017for TMX Group, please click on the following link: http://www.tmx.com/investor-relations/ About TMX Group (TSX:X) TMX Read more...

Quotient Limited Reports Blood Grouping Concordance Data From MosaiQ Verification and Validation Studies and Updates on the Completion of Its Sale Leaseback Transaction

Verification & Validation (“V&V”) “head-to-head” data exceeds target concordance for blood groupingOverall concordance for antigen typing – 99.8%, demonstrating robustness of the MosaiQ platformCompletion of the BioCampus sale and leaseback transaction JERSEY, Channel Islands, March 26, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diag...

Genetic Technologies Limited Announces Further Collaborative Research with The University of Melbourne to Broaden the Applicability of the BREVAGenplus® Breast Cancer Risk Assessment Test

MELBOURNE, Australia, March 16, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms, announced today the execution of a research and services agreement with The University of Melbourne for the further development and enhancement of the BREVA...

Global MultiWalled Carbon Nanotubes Market Research Report 20112023 [Report Updated: 10012018] Prices from USD $3560

SummaryThe global MultiWalled Carbon Nanotubes market will reach xxx Million USD in 2017 with CAGR xx% 20182023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.Based on products type, the report de...

Maricann Group Inc.: Maricann Group expandiert in -2-

DJ Maricann Group Inc.: Maricann Group expandiert in den Spirituosenmarkt - genau wie Canopy Growth! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein N...

Maricann Group Inc.: Maricann Group - Lizenz zur -2-

DJ Maricann Group Inc.: Maricann Group - Lizenz zur Produktion von Cannabis Kapseln! - Übernahmeangebote bei Konkurrenten! Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Presse...

North 6th Agency Announces N6-Accolades For March 2018

The N6A Cybersecurity & Digital Identity Group took home the "N6A Golden Group" trophy as the highest-performing group for the month. At the end of Read more...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks